Susquehanna International Group, LLP Recursion Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$5.92 - $8.6 $1.46 Million - $2.12 Million	-246,200 Reduced 19.62%	1,008,600 $6.65 Million
Q2 2024 Aug 15, 2024	BUY	$7.35 - $10.05 $3.38 Million - $4.62 Million	459,400 Added 57.76%	1,254,800 $9.41 Million
Q1 2024 May 07, 2024	BUY	$9.13 - $15.52 $5.43 Million - $9.23 Million	594,400 Added 295.72%	795,400 $7.93 Million
Q4 2023 Feb 14, 2024	SELL	$5.09 - $10.79 $353,246 - $748,825	-69,400 Reduced 25.67%	201,000 $1.98 Million
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $1.23 Million - $2.95 Million	186,100 Added 220.76%	270,400 $2.07 Million
Q2 2023 Aug 11, 2023	BUY	$4.56 - $9.94 $237,575 - $517,874	52,100 Added 161.8%	84,300 $629,000
Q1 2023 May 16, 2023	BUY	$6.42 - $9.64 $131,610 - $197,620	20,500 Added 175.21%	32,200 $214,000
Q4 2022 Feb 14, 2023	SELL	$7.16 - $12.7 $23,628 - $41,910	-3,300 Reduced 22.0%	11,700 $90,000
Q3 2022 Nov 14, 2022	SELL	$7.83 - $13.6 $92,394 - $160,480	-11,800 Reduced 44.03%	15,000 $160,000

289

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.16B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.